Tom Lanz (Senior Director, Multi-Omics and Biomarkers, Pfizer) explains how AI-powered multi-omics is improving drug safety.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results